Evidence map›Paper›PMID 28703301›Full record

ArticleJournal of cellular physiology2018

The xenoestrogens biphenol-A and nonylphenol differentially regulate metalloprotease-mediated shedding of EGFR ligands.

Paulina Urriola-Muñoz, Xue Li, Thorsten Maretzky, David R McIlwain, Tak W Mak, Juan G Reyes, Carl P Blobel, Ricardo D Moreno

Abstract read
In one paragraph

Article in Journal of cellular physiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.6field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. iRhom2: An Emerging Adaptor Regulating Immunity and Disease.International journal of molecular sciences · 2020
    Review
  5. Targeting ADAM10 in Cancer and Autoimmunity.Frontiers in immunology · 2020
    Review
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 4 countries.

Paulina Urriola-MuñozFacultad de Ciencias Biológicas, Departamento de Fisiología, Pontificia Universidad Católica de Chile, Santiago, Chile.
Xue LiArthritis and Tissue Degeneration Program, Hospital for Special Surgery, New York, New York.
Thorsten MaretzkyArthritis and Tissue Degeneration Program, Hospital for Special Surgery, New York, New York.
David R McIlwainDepartment of Microbiology and Immunology, Baxter Laboratory in Stem Cell Biology, Stanford University, Stanford, California.
Tak W MakCampbell Family Institute for Breast Cancer Research, Princess Margaret Cancer Center, University Health Network, Toronto, Ontario, Canada.
Juan G ReyesInstituto de Química, Pontificia Universidad Católica de Valparaíso, Valparaíso, Chile.
Carl P BlobelArthritis and Tissue Degeneration Program, Hospital for Special Surgery, New York, New York.
Ricardo D MorenoFacultad de Ciencias Biológicas, Departamento de Fisiología, Pontificia Universidad Católica de Chile, Santiago, Chile.ORCID http://orcid.org/0000-0002-7499-5501
Hospital for Special Surgery · USPontificia Universidad Católica de Valparaíso · CLPontificia Universidad Católica de Chile · CLStanford University · USUniversity Health Network · CA

Funding

Viral VectorP30CA086862 · NCI · UNIVERSITY OF IOWA · PI Douglas Robert Spitz · 2000 to 2026
$70.0M
iRhoms 1 and 2: Key regulators of ADAM17-dependent EGFR signalingR01GM064750 · NIGMS · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI BLOBEL, CARL PETER · 2002 to 2019
$6.1M
NIGMS NIH HHS R01 GM064750
6 · The paper itself

Abstract

The xenoestrogens bisphenol-A (BPA) and nonylphenol (NP) are endocrine disruptors used in the plastic polymer industry to manufacture different products for human use. Previous studies have suggested a role of these compounds in the shedding of signaling molecules, such as tumor necrosis factor α (TNF-α). The aim of this work was to evaluate the effect of BPA and NP on the sheddase ADAM17 and its newly discovered regulators iRhom1 and iRhom2 in the release of EGFR-ligands. We report that BPA and NP can stimulate the release of the ADAM17-substrates HB-EGF and TGF-α. In cells lacking ADAM17 (Adam17

Indexed as

ADAM10 ProteinADAM17 ProteinAmyloid Precursor Protein SecretasesAnimalsBenzhydryl CompoundsBisphenol A CompoundsCarrier ProteinsCell LineDose-Response Relationship, DrugEndocrine DisruptorsEnzyme ActivationErbB ReceptorsEstrogensFibroblastsHeparin-binding EGF-like Growth FactorLigandsADAM10 ProteinAdam10 protein, mouseADAM17 ProteinAdam17 protein, mouseAmyloid Precursor Protein SecretasesBenzhydryl Compoundsbisphenol ABisphenol A CompoundsCarrier ProteinsEGFR protein, mouseEndocrine DisruptorsErbB ReceptorsEstrogensHeparin-binding EGF-like Growth FactoriRhom1 protein, mouseiRhom2 protein, mouseLigandsMembrane ProteinsnonylphenolPhenolsTumor Necrosis Factor-alphaADAMepidermal growth factor receptor (EGFR)growth factorxenobiotic

Identifiers

PMID28703301
PMCPMC5705578
OpenAlexW2736052705

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.